Yahoo
NSE - Delayed Quote INR

Vijaya Diagnostic Centre Limited (VIJAYA.NS)

1,445.70 -18.50 (-1.26%)
At close: October 30 at 3:29:56 PM GMT+5:30
Chart Range Bar
Loading chart for VIJAYA.NS
  • Previous Close 1,464.20
  • Open 1,446.10
  • Bid --
  • Ask --
  • Day's Range 1,435.10 - 1,478.90
  • 52 Week Range 848.00 - 1,593.60
  • Volume 50,161
  • Avg. Volume 166,714
  • Market Cap (intraday) 148.904B
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) 79.48
  • EPS (TTM) 18.19
  • Earnings Date --
  • Forward Dividend & Yield 2.00 (0.14%)
  • Ex-Dividend Date Sep 16, 2026
  • 1y Target Est 1,554.80

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, and molecular diagnostics; radiology services, such as CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, and gastroenterology; and advance radiology service comprising nuclear medicine, positron emission tomography CT, and MRI-3T services. It also provides health checkups and home sample collection services, as well as test services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.

www.vijayadiagnostic.com

2,507

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

VIJAYA.NS
36.45%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

VIJAYA.NS
45.53%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

VIJAYA.NS
151.34%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

VIJAYA.NS
158.45%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 2.31B
Earnings 531.01M
Profit Margin 22.99%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
500M
1B
2B
2B
21.5%
22.0%
22.5%

Analyst Insights

View More

Analyst Price Targets

1,400.00 Low
1,554.80 Average
1,445.70 Current
1,700.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.87%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    8.57B

  • Net Income Avi to Common (ttm)

    1.87B

  • Diluted EPS (ttm)

    18.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.89B

  • Total Debt/Equity (mrq)

    44.15%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: